Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
Oncolytic viruses (OVs) replicate selectively in tumor cells and exert anti-tumor cytotoxic activity. Among them, Newcastle Disease Virus (NDV), a bird RNA virus of the paramyxovirus family, appears outstanding. Its anti-tumor effect is based on: (i) oncolytic activity and (ii) immunostimulation. To...
Main Authors: | Philippe Fournier, Volker Schirrmacher |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-07-01
|
Series: | Biology |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-7737/2/3/936 |
Similar Items
-
Multimodal cancer therapy involving oncolytic Newcastle Disease Virus, autologous immune cells and bispecific antibodies
by: Volker eSchirrmacher, et al.
Published: (2014-09-01) -
Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!
by: Volker Schirrmacher
Published: (2016-07-01) -
Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.
by: Tiphaine Delaunay, et al.
Published: (2018-03-01) -
Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy
by: Youra Kim, et al.
Published: (2015-12-01) -
Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors
by: Victor Cervera-Carrascon, et al.
Published: (2020-06-01)